Results 201 to 210 of about 102,940,073 (295)
PULPO: pipeline of understanding large-scale patterns of oncogenomic signatures. [PDF]
Portasany-Rodríguez M +11 more
europepmc +1 more source
Single CTC analysis revealed extensive inter‐ and intra‐patient heterogeneity of PI3K/AKT/PTEN pathway alterations in HR+/HER2− metastatic breast cancer, capturing both SNVs and CNAs, including PTEN loss‐of‐function events. Longitudinal CTC profiling also uncovered dynamic clonal evolution, highlighting its potential to complement tissue and ctDNA ...
Tania Rossi +10 more
wiley +1 more source
The UVA-induced single-base mutational signature of CX-5461 in human cells. [PDF]
Zaikova E +13 more
europepmc +1 more source
In patients with esophageal squamous cell carcinoma receiving definitive radiotherapy combined with systemic therapy, posttreatment TP53 mutation clearance and ctDNA‐MRD negativity predict favorable outcomes, whereas persistent ctDNA signals indicate elevated relapse risk, supporting nucleosome‐ and MRD‐informed surveillance and risk‐stratification ...
Shutang Liu +9 more
wiley +1 more source
COSMIC-Linked Ras Mutations at the Interface Between H-Ras and PI3Kγ<sub>RBD</sub> Frequently Generate Affinity Increases. [PDF]
Mead EH +11 more
europepmc +1 more source
A customized panel was established for BTC MRD detection. Preoperative ctDNA detection was associated with pathological stage and poorer RFS and OS. Longitudinal monitoring detected ctDNA before radiological recurrence in 72.7% of patients, with a median lead time of 77 days, supporting ctDNA as a complementary prognostic biomarker with CA19‐9 ...
Yoshihito Shinohara +13 more
wiley +1 more source
Mapping Mutations and Signaling Network Interactions to Guide Precision Therapy in Gallbladder Cancer. [PDF]
Manav N +4 more
europepmc +1 more source
We describe a girl presenting with structural eye anomalies and a constellation of features suggestive of the mosaic RASopathy EncephaloCranioCutaneous Lipomatosis (ECCL). Tissue‐specific investigations identified a mosaic KRAS variant at a mutational hotspot (p.[Ala146Pro]), prompting appropriate tumour surveillance.
Karthikah Jeganathan +8 more
wiley +1 more source
Mutational signature refitting on sparse pan-cancer data. [PDF]
Gilad G, Przytycka TM, Sharan R.
europepmc +1 more source

